Immunic公司宣布,将在MSToronto2026——即第十届ACTRIMS-ECTRIMS联合会议上,公布关于Vidofludimus Calcium的最新临床、生物标志物以及临床前研究数据。
Immunic公司宣布,将在MSToronto2026——即第十届ACTRIMS-ECTRIMS联合会议上,公布关于Vidofludimus Calcium的最新临床、生物标志物以及临床前研究数据。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.